Literature DB >> 9930755

Structure and functional characterization of a novel human low-voltage activated calcium channel.

M E Williams1, M S Washburn, M Hans, A Urrutia, P F Brust, P Prodanovich, M M Harpold, K A Stauderman.   

Abstract

We have isolated and characterized overlapping cDNAs encoding a novel, voltage-gated Ca2+ channel alpha1 subunit, alpha1H, from a human medullary thyroid carcinoma cell line. The alpha1H subunit is structurally similar to previously described alpha1 subunits. Northern blot analysis indicates that alpha1H mRNA is expressed throughout the brain, primarily in the amygdala, caudate nucleus, and putamen, as well as in several nonneuronal tissues, with relatively high levels in the liver, kidney, and heart. Ba2+ currents recorded from human embryonic kidney 293 cells transiently expressing alpha1H activated at relatively hyperpolarized potentials (-50 mV), rapidly inactivated (tau = 17 ms), and slowly deactivated. Similar results were observed in Xenopus oocytes expressing alpha1H. Single-channel measurements in human embryonic kidney 293 cells revealed a single-channel conductance of approximately 9 pS. These channels are blocked by Ni2+ (IC50 = 6.6 microM) and the T-type channel antagonists mibefradil (approximately 50% block at 1 microM) and amiloride (IC50 = 167 microM). Thus, alpha1H-containing channels exhibit biophysical and pharmacological properties characteristic of low voltage-activated, or T-type, Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9930755     DOI: 10.1046/j.1471-4159.1999.0720791.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

1.  Alternatively spliced alpha(1G) (Ca(V)3.1) intracellular loops promote specific T-type Ca(2+) channel gating properties.

Authors:  J Chemin; A Monteil; E Bourinet; J Nargeot; P Lory
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

2.  Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability.

Authors:  Jean Chemin; Arnaud Monteil; Edward Perez-Reyes; Emmanuel Bourinet; Joël Nargeot; Philippe Lory
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

3.  Cloning and expression of the human T-type channel Ca(v)3.3: insights into prepulse facilitation.

Authors:  Juan Carlos Gomora; Janet Murbartián; Juan Manuel Arias; Jung-Ha Lee; Edward Perez-Reyes
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

4.  Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line.

Authors:  Jean Chemin; Joël Nargeot; Philippe Lory
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 5.  Low-voltage-activated ("T-Type") calcium channels in review.

Authors:  Anne Marie R Yunker; Maureen W McEnery
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 6.  Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.

Authors:  Anne Marie R Yunker
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

7.  Recruitment of apical dendritic T-type Ca2+ channels by backpropagating spikes underlies de novo intrinsic bursting in hippocampal epileptogenesis.

Authors:  Yoel Yaari; Cuiyong Yue; Hailing Su
Journal:  J Physiol       Date:  2007-02-01       Impact factor: 5.182

8.  KV7/M channels mediate osmotic modulation of intrinsic neuronal excitability.

Authors:  Anna Caspi; Felix Benninger; Yoel Yaari
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

9.  The relationship between single-channel and whole-cell conductance in the T-type Ca2+ channel CaV3.1.

Authors:  Katie C Bittner; Dorothy A Hanck
Journal:  Biophys J       Date:  2008-03-28       Impact factor: 4.033

10.  High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.

Authors:  P Eller; S Berjukov; S Wanner; I Huber; S Hering; H G Knaus; G Toth; S D Kimball; J Striessnig
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.